Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond T Chung

Showing results (41-50 of 616) with videos related to

Pageof 62
Sort By:
Gastroenterology|August 8, 2007
p53 restoration leads to tumor senescence and regression: implications for cancer therapyAndrew W Tai, Raymond T Chung
The Journal of Infectious Diseases|November 27, 2020
Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?Andre J Jeyarajan, Raymond T Chung
Hepatology (Baltimore, Md.)|August 29, 2015
ReplyTracey G Simon, Raymond T Chung
Nature Reviews. Gastroenterology & Hepatology|March 24, 2016
Viral hepatitis: HCV compartmentalization in HCC: driver, passenger or both?Jacinta A Holmes, Raymond T Chung
Cancer|August 20, 2015
Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?Darrick K Li, Raymond T Chung
The Journal of Infectious Diseases|September 13, 2023
Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus EradicationEric M Przybyszewski, Raymond T Chung
Gastroenterology|January 25, 2011
Can we use the "C" word with confidence? Cure for chronic hepatitis CJennifer Y Chen, Raymond T Chung
Methods in Molecular Biology (Clifton, N.J.)|December 30, 2018
Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C VirusDarrick K Li, Raymond T Chung
BMJ (Clinical Research Ed.)|July 9, 2014
Antiviral treatment of hepatitis CEoin R Feeney, Raymond T Chung
The New England Journal of Medicine|April 12, 2014
Curing chronic hepatitis C--the arc of a medical triumphRaymond T Chung, Thomas F Baumert
Pageof 62

Showing results (41-50 of 616) with videos related to

Sort By:
Pageof 62
Gastroenterology|August 8, 2007
p53 restoration leads to tumor senescence and regression: implications for cancer therapyAndrew W Tai, Raymond T Chung
The Journal of Infectious Diseases|November 27, 2020
Insights Into the Pathophysiology of Liver Disease in HCV/HIV: Does it End With HCV Cure?Andre J Jeyarajan, Raymond T Chung
Hepatology (Baltimore, Md.)|August 29, 2015
ReplyTracey G Simon, Raymond T Chung
Nature Reviews. Gastroenterology & Hepatology|March 24, 2016
Viral hepatitis: HCV compartmentalization in HCC: driver, passenger or both?Jacinta A Holmes, Raymond T Chung
Cancer|August 20, 2015
Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution?Darrick K Li, Raymond T Chung
The Journal of Infectious Diseases|September 13, 2023
Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus EradicationEric M Przybyszewski, Raymond T Chung
Gastroenterology|January 25, 2011
Can we use the "C" word with confidence? Cure for chronic hepatitis CJennifer Y Chen, Raymond T Chung
Methods in Molecular Biology (Clifton, N.J.)|December 30, 2018
Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C VirusDarrick K Li, Raymond T Chung
BMJ (Clinical Research Ed.)|July 9, 2014
Antiviral treatment of hepatitis CEoin R Feeney, Raymond T Chung
The New England Journal of Medicine|April 12, 2014
Curing chronic hepatitis C--the arc of a medical triumphRaymond T Chung, Thomas F Baumert
Pageof 62